NeurOp, Inc. is a biotechnology company developing new medicines for central nervous system disorders including depression, neuropathic pain, ischemia (stroke), schizophrenia and Parkinson’s disease.

Latest News

NeurOp Selected to Compete in RESI 2017 Innovation Challenge - Sept 26th, Boston

read more...

Our Science

Our compounds are designed to target various subunits of N-methyl-D-aspartate (NMDA) receptors.

About Us

Our expertise in a critical signaling pathway in the central nervous system is leading to promising drug compounds.